Commentary Open Access
Volume 4 | Issue 1 | DOI: https://doi.org/10.46439/Neuroscience.4.021
Unusual presentations of shunt malfunction - A commentary
Mehrdad Pahlevani, MD1, Zohreh Habibi, MD1, Mostafa EL Khashab, MD, PhD2, Farideh Nejat, MD, MPH1.*
- 1Department of Neurosurgery, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran
- 2Department of Neurosurgery, Hackensack University Medical Center, NJ, USA
Corresponding Author
Farideh Nejat, nejat@sina.tums.ac.ir
Received Date: March 12, 2024
Accepted Date: May 15, 2024
Pahlevani M, Habibi Z, Khashab ME, Nejat F. Unusual presentations of shunt malfunction - A commentary. Neurosci Chron. 2024;4(1):21-23.
Copyright: © 2024 Pahlevani M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords
Complication, Ptosis, Facial palsy, Torticollis, Shunt
Recommended Articles
Exploring novel therapeutic avenues for arthritis precision medicine: The potential of mTOR-SIRT1, NRF2, GPX4 ferroptosis- and autophagy- related pathways and emerging technologies
Arthritis remains a common and debilitating disease affecting millions of people worldwide. Osteoarthritis (OA) and rheumatoid arthritis (RA) are among the most common forms of this chronic, degenerative disease, which is moving toward precision medicine.
The extract of Nicotiana glauca induces apoptosis in rhabdomyosarcoma cells
Cancer is a leading cause of childhood mortality, with rhabdomyosarcoma (RMS) being the most prevalent type diagnosed in approximately two-thirds of pediatric cancer cases, particularly the embryonal subtype. RMS represents the most common soft tissue sarcoma in children and adolescents, accounting for around 2-3.5% of all pediatric malignancies [1].
Toward a new approach to treating tumors: Inducing apoptosis by combining chemotherapy and mild hyperthermia
Our studies on the effects of mild hyperthermia (≤ 42°C) on prometaphase-arrested and interphase HeLa cells are reviewed. Mild heat treatment rapidly induces apoptosis in H-HeLa cells that have been arrested in prometaphase with spindle poisons. This is shown by the appearance of morphological changes characteristic of apoptosis, the activation of Caspase 3, and the fact that the changes are blocked by caspase inhibitors such as zVAD-fmk. The same treatment does not cause apoptosis in interphase cells, or in prometaphase-arrested cells of other HeLa strains such as HeLa S3, MKF, and WML. However, prometaphase-arrested cultures of those other HeLa strains can be made sensitive to mild heat treatment by simultaneous exposure to compounds such as navitoclax (ABT-263) which inhibit Bcl-2 family anti-apoptotic proteins. Interphase cells can be made sensitive to 42°C treatment by combining ABT-263 or ABT-199 with S63845, a potent and selective inhibitor of MCL-1.
Targeting Caspase-4 and pyroptosis as a new therapeutic approach for asthma
Asthma is a chronic inflammatory disease of the lung caused by a combination of environmental and genetic factors. Although symptoms of mild asthma are treated with current medications, such as bronchodilators and steroids, severe asthma remains very difficult to manage. Asthma rates are constantly on the rise and there is a clear need for novel asthma therapies especially in severe asthma.
Regulating ferroptosis by glutathione s-transferases: From mechanistic to potential therapeutic targets
Ferroptosis is a type of cell death caused by iron-dependent lipid peroxidation. In recent years, certain isoforms of glutathione-S-transferases (GSTs) have been identified that may play a key role in regulating ferroptosis. Previous study demonstrated that the NRF2/GSH/GST/RLIP76 and MRP1 axis acts as an independent anti-ferroptosis pathway. Furthermore, this study evaluated the therapeutic potential of mifepristone (RU486) for mitigating acetaminophen (APAP)-induced liver injury in vivo.